Shaanxi pharmaceutical new project

The planned land area for this project is approximately 23.2 acres, with the total construction area being about 45,000m2. Approximately 24,000m2 is planned for the production workshops while approximately 20,000m2 and 500m2 are planned for R&D building and the raw material warehouse respectively. The research and develop will focus on drugs for respiratory system, cardiovascular system, anti-infection and anti-virus fields.

Production of nitroglycerin for

quick acting Jiuxin Pill Etc. for the treatment of hypertension, angina pectoris and other diseases which will be exported to India, and other country.

In order to achieve SPCL’s goal of long-term stable and high-quality development, it is necessary to implement this project because of its current poor capacities of hardware and facilities, and insufficient production capacity. In view of the current situation of SPCL’s hardware and facilities, we will expand and restructure the existing plants and workshops. That is, we will purchase advanced production equipment units and adjust arrangements of the existing comprehensive workshop to provide functional houses for promoting production capacities, improving product quality and increasing number of new drug varieties.